ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,289.21
0.81%
US Tech 100
18,012.00
0.98%
다우존스 지수
39,782.66
0.57%
Bitcoin
64,875.42
5.41%
Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Xeris Biopharma Holdings Inc (XERS)

  7. Xeris Biopharma Holdings Inc (XERS) 뉴스

XERS

Xeris Biopharma (XERS)

Xeris Biopharma Holdings Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:XERS
일자시간출처헤드라인심볼기업
2024/05/0920:14Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XERSXeris Biopharma Holdings Inc
2024/05/0920:00Business WireXeris Biopharma Reports First Quarter 2024 Financial Results and Recent EventsNASDAQ:XERSXeris Biopharma Holdings Inc
2024/05/0620:00Business WireXeris Enters Into an Exclusive Worldwide Collaboration and License Agreement with Beta BionicsNASDAQ:XERSXeris Biopharma Holdings Inc
2024/05/0220:00Business WireXeris Biopharma to Report First Quarter 2024 Financial Results on May 9, 2024NASDAQ:XERSXeris Biopharma Holdings Inc
2024/04/0405:05Business WireXeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:XERSXeris Biopharma Holdings Inc
2024/04/0220:00Business WireXeris Biopharma to Participate in the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:XERSXeris Biopharma Holdings Inc
2024/03/0706:19Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:XERSXeris Biopharma Holdings Inc
2024/03/0706:10Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:XERSXeris Biopharma Holdings Inc
2024/03/0621:27Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XERSXeris Biopharma Holdings Inc
2024/03/0621:02Business WireXeris Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent EventsNASDAQ:XERSXeris Biopharma Holdings Inc
2024/03/0621:00Business WireXeris Refinances Its $150M Senior Secured Term Loan Facility With Hayfin CapitalNASDAQ:XERSXeris Biopharma Holdings Inc
2024/02/2821:00Business WireXeris Biopharma to Report Fourth Quarter and Full Year 2023 Financial Results on March 6, 2024NASDAQ:XERSXeris Biopharma Holdings Inc
2024/02/0521:00Business WireXeris to Present at the Oppenheimer 34th Annual Healthcare Life Science ConferenceNASDAQ:XERSXeris Biopharma Holdings Inc
2024/02/0107:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XERSXeris Biopharma Holdings Inc
2024/01/1100:12Dow Jones NewsXeris Biopharma Shares Climb 12% on Amgen License AgreementNASDAQ:XERSXeris Biopharma Holdings Inc
2024/01/1022:53Dow Jones NewsXeris Biopharma Reaches License Agreement With Amgen On Thyroid Eye Disease TreatmentNASDAQ:XERSXeris Biopharma Holdings Inc
2024/01/1022:00Business WireXeris Biopharma Enters Into an Exclusive Worldwide License Agreement for Xeriject® Formulation of TeprotumumabNASDAQ:XERSXeris Biopharma Holdings Inc
2024/01/0606:05Business WireXeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:XERSXeris Biopharma Holdings Inc
2024/01/0421:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XERSXeris Biopharma Holdings Inc
2024/01/0421:00Business WireXeris Biopharma Updates Its Outlook for 2023NASDAQ:XERSXeris Biopharma Holdings Inc
2023/12/2721:00Business WireXeris Biopharma to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:XERSXeris Biopharma Holdings Inc
2023/11/2206:16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XERSXeris Biopharma Holdings Inc
2023/11/1006:10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:XERSXeris Biopharma Holdings Inc
2023/11/0921:20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XERSXeris Biopharma Holdings Inc
2023/11/0921:00Business WireXeris Biopharma Reports Third Quarter 2023 Financial ResultsNASDAQ:XERSXeris Biopharma Holdings Inc
2023/10/1620:12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XERSXeris Biopharma Holdings Inc
2023/10/1620:00Business WireXeris Biopharma Raises Full-Year Financial Guidance and Reaffirms Cash Flow Breakeven in Q4 2023NASDAQ:XERSXeris Biopharma Holdings Inc
2023/09/3005:55Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XERSXeris Biopharma Holdings Inc
2023/09/2721:11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XERSXeris Biopharma Holdings Inc
2023/09/2721:00Business WireXeris Biopharma Announces Private Convertible Note Exchange TransactionsNASDAQ:XERSXeris Biopharma Holdings Inc
 검색 관련기사 보기:NASDAQ:XERS

최근 히스토리

USOTC
DTEGY
Deutsche Telekom (QX)
USOTC
RHHBY
Roche (QX)
NYSE
CVX
Chevron
SPI
SP500
S&P 500
AMEX
SPY
SPDR S&P 500
NYSE
BAC
Bank of America
PM
XAUUSD
Gold vs US Dollar
NASDAQ
AAPL
Apple
NASDAQ
AMZN
Amazon.com
CCOM
SILVER
SILVER
FX
USDGBP
US Dollar vs Sterling
USI
USTECH100
US Tech 100
NASDAQ
NVDA
NVIDIA
NASDAQ
GOOGL
Alphabet
AMEX
XLE
Energy Select Sector SPDR
FX
USDJPY
US Dollar vs Yen
Delayed Upgrade Clock
ADVFN Logo

대한민국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유